Cargando…

Organ-Specific MicroRNAs (MIR122, 137, and 206) Contribute to Tissue Characteristics and Carcinogenesis by Regulating Pyruvate Kinase M1/2 (PKM) Expression

Pyruvate kinase is known as the glycolytic enzyme catalyzing the final step in glycolysis. In mammals, two different forms of it exist, i.e., pyruvate kinase M1/2 (PKM) and pyruvate kinase L/R (PKLR). Also, PKM has two isoforms, i.e., PKM1 and PKM2. These genes have tissue-specific distribution. Nam...

Descripción completa

Detalles Bibliográficos
Autores principales: Taniguchi, Kohei, Sugito, Nobuhiko, Shinohara, Haruka, Kuranaga, Yuki, Inomata, Yosuke, Komura, Kazumasa, Uchiyama, Kazuhisa, Akao, Yukihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983799/
https://www.ncbi.nlm.nih.gov/pubmed/29695138
http://dx.doi.org/10.3390/ijms19051276
_version_ 1783328502392553472
author Taniguchi, Kohei
Sugito, Nobuhiko
Shinohara, Haruka
Kuranaga, Yuki
Inomata, Yosuke
Komura, Kazumasa
Uchiyama, Kazuhisa
Akao, Yukihiro
author_facet Taniguchi, Kohei
Sugito, Nobuhiko
Shinohara, Haruka
Kuranaga, Yuki
Inomata, Yosuke
Komura, Kazumasa
Uchiyama, Kazuhisa
Akao, Yukihiro
author_sort Taniguchi, Kohei
collection PubMed
description Pyruvate kinase is known as the glycolytic enzyme catalyzing the final step in glycolysis. In mammals, two different forms of it exist, i.e., pyruvate kinase M1/2 (PKM) and pyruvate kinase L/R (PKLR). Also, PKM has two isoforms, i.e., PKM1 and PKM2. These genes have tissue-specific distribution. Namely, PKM1 is distributed in high-energy-demanding organs, such as brain and muscle. Also, PKM2 is distributed in various other organs, such as the colon. On the other hand, PKLR is distributed in liver and red blood cells (RBCs). Interestingly, PKM2 has been recognized as one of the essential genes for the cancer-specific energy metabolism termed the “Warburg effect”. However, the mechanism(s) underlying this fact have remained largely unclear. Recently, we found that some organ-specific microRNAs (miRNAs, MIR) regulate PKM isoform expression through direct targeting of polypyrimidine tract binding protein 1 (PTBP1), which is the splicer responsible for PKM2-dominant expression. In this study, we examined whether this machinery was conserved in the case of other PTBP1- and PKM-targeting miRNAs. We focused on the MIRs 122, 137, and 206, and investigated the expression profiles of each of these miRNAs in tissues from mouse and human organs. Also, we examined the regulatory mechanisms of PKM isoform expression by testing each of these miRNAs in human cancer cell lines. Presently, we found that brain-specific MIR137 and muscle-specific MIR206 predominantly induced PKM1 expression through direct targeting of PTBP1. Also, liver-specific MIR122 suppressed the expression of both PKM1 and PKM2, which action occurred through direct targeting of PKM to enable the expression of PKLR. Moreover, the expression levels of these miRNAs were downregulated in cancer cells that had originated from these tissues, resulting in PKM2 dominance. Our results suggest that the organ-specific distribution of miRNAs is one of the principal means by which miRNA establishes characteristics of a tissue and that dysregulation of these miRNAs results in cancer development through a change in the ratio of PKM isoform expression. Also, our results contribute to cancer diagnosis and will be useful for cancer-specific therapy for the Warburg effect in the near future.
format Online
Article
Text
id pubmed-5983799
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-59837992018-06-05 Organ-Specific MicroRNAs (MIR122, 137, and 206) Contribute to Tissue Characteristics and Carcinogenesis by Regulating Pyruvate Kinase M1/2 (PKM) Expression Taniguchi, Kohei Sugito, Nobuhiko Shinohara, Haruka Kuranaga, Yuki Inomata, Yosuke Komura, Kazumasa Uchiyama, Kazuhisa Akao, Yukihiro Int J Mol Sci Article Pyruvate kinase is known as the glycolytic enzyme catalyzing the final step in glycolysis. In mammals, two different forms of it exist, i.e., pyruvate kinase M1/2 (PKM) and pyruvate kinase L/R (PKLR). Also, PKM has two isoforms, i.e., PKM1 and PKM2. These genes have tissue-specific distribution. Namely, PKM1 is distributed in high-energy-demanding organs, such as brain and muscle. Also, PKM2 is distributed in various other organs, such as the colon. On the other hand, PKLR is distributed in liver and red blood cells (RBCs). Interestingly, PKM2 has been recognized as one of the essential genes for the cancer-specific energy metabolism termed the “Warburg effect”. However, the mechanism(s) underlying this fact have remained largely unclear. Recently, we found that some organ-specific microRNAs (miRNAs, MIR) regulate PKM isoform expression through direct targeting of polypyrimidine tract binding protein 1 (PTBP1), which is the splicer responsible for PKM2-dominant expression. In this study, we examined whether this machinery was conserved in the case of other PTBP1- and PKM-targeting miRNAs. We focused on the MIRs 122, 137, and 206, and investigated the expression profiles of each of these miRNAs in tissues from mouse and human organs. Also, we examined the regulatory mechanisms of PKM isoform expression by testing each of these miRNAs in human cancer cell lines. Presently, we found that brain-specific MIR137 and muscle-specific MIR206 predominantly induced PKM1 expression through direct targeting of PTBP1. Also, liver-specific MIR122 suppressed the expression of both PKM1 and PKM2, which action occurred through direct targeting of PKM to enable the expression of PKLR. Moreover, the expression levels of these miRNAs were downregulated in cancer cells that had originated from these tissues, resulting in PKM2 dominance. Our results suggest that the organ-specific distribution of miRNAs is one of the principal means by which miRNA establishes characteristics of a tissue and that dysregulation of these miRNAs results in cancer development through a change in the ratio of PKM isoform expression. Also, our results contribute to cancer diagnosis and will be useful for cancer-specific therapy for the Warburg effect in the near future. MDPI 2018-04-24 /pmc/articles/PMC5983799/ /pubmed/29695138 http://dx.doi.org/10.3390/ijms19051276 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Taniguchi, Kohei
Sugito, Nobuhiko
Shinohara, Haruka
Kuranaga, Yuki
Inomata, Yosuke
Komura, Kazumasa
Uchiyama, Kazuhisa
Akao, Yukihiro
Organ-Specific MicroRNAs (MIR122, 137, and 206) Contribute to Tissue Characteristics and Carcinogenesis by Regulating Pyruvate Kinase M1/2 (PKM) Expression
title Organ-Specific MicroRNAs (MIR122, 137, and 206) Contribute to Tissue Characteristics and Carcinogenesis by Regulating Pyruvate Kinase M1/2 (PKM) Expression
title_full Organ-Specific MicroRNAs (MIR122, 137, and 206) Contribute to Tissue Characteristics and Carcinogenesis by Regulating Pyruvate Kinase M1/2 (PKM) Expression
title_fullStr Organ-Specific MicroRNAs (MIR122, 137, and 206) Contribute to Tissue Characteristics and Carcinogenesis by Regulating Pyruvate Kinase M1/2 (PKM) Expression
title_full_unstemmed Organ-Specific MicroRNAs (MIR122, 137, and 206) Contribute to Tissue Characteristics and Carcinogenesis by Regulating Pyruvate Kinase M1/2 (PKM) Expression
title_short Organ-Specific MicroRNAs (MIR122, 137, and 206) Contribute to Tissue Characteristics and Carcinogenesis by Regulating Pyruvate Kinase M1/2 (PKM) Expression
title_sort organ-specific micrornas (mir122, 137, and 206) contribute to tissue characteristics and carcinogenesis by regulating pyruvate kinase m1/2 (pkm) expression
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983799/
https://www.ncbi.nlm.nih.gov/pubmed/29695138
http://dx.doi.org/10.3390/ijms19051276
work_keys_str_mv AT taniguchikohei organspecificmicrornasmir122137and206contributetotissuecharacteristicsandcarcinogenesisbyregulatingpyruvatekinasem12pkmexpression
AT sugitonobuhiko organspecificmicrornasmir122137and206contributetotissuecharacteristicsandcarcinogenesisbyregulatingpyruvatekinasem12pkmexpression
AT shinoharaharuka organspecificmicrornasmir122137and206contributetotissuecharacteristicsandcarcinogenesisbyregulatingpyruvatekinasem12pkmexpression
AT kuranagayuki organspecificmicrornasmir122137and206contributetotissuecharacteristicsandcarcinogenesisbyregulatingpyruvatekinasem12pkmexpression
AT inomatayosuke organspecificmicrornasmir122137and206contributetotissuecharacteristicsandcarcinogenesisbyregulatingpyruvatekinasem12pkmexpression
AT komurakazumasa organspecificmicrornasmir122137and206contributetotissuecharacteristicsandcarcinogenesisbyregulatingpyruvatekinasem12pkmexpression
AT uchiyamakazuhisa organspecificmicrornasmir122137and206contributetotissuecharacteristicsandcarcinogenesisbyregulatingpyruvatekinasem12pkmexpression
AT akaoyukihiro organspecificmicrornasmir122137and206contributetotissuecharacteristicsandcarcinogenesisbyregulatingpyruvatekinasem12pkmexpression